Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases

被引:504
作者
Pawar, AP
DuBay, KF
Zurdo, J
Chiti, F
Vendruscolo, M
Dobson, CM
机构
[1] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England
[2] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy
基金
英国惠康基金;
关键词
amyloid; sensitive regions; protein aggregation; protein misfolding;
D O I
10.1016/j.jmb.2005.04.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence indicates that many peptides and proteins can be converted in vitro into highly organised amyloid structures, provided that the appropriate experimental conditions can be found. In this work, we define intrinsic propensities for the aggregation of individual amino acids and develop a method for identifying the regions of the sequence of an unfolded peptide or protein that are most important for promoting amyloid formation. This method is applied to the study of three polypeptides associated with neurodegenerative diseases, A beta 42, a-synuclein and tau. In order to validate the approach, we compare the regions of proteins that are predicted to be most important in driving aggregation, either intrinsically or as the result of mutations, with those determined experimentally. The knowledge of the location and the type of the "sensitive regions" for aggregation is important both for rationalising the effects of sequence changes on the aggregation of polypeptide chains and for the development of targeted strategies to combat diseases associated with amyloid formation. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 392
页数:14
相关论文
共 100 条
[1]   INCREASED BODY-TEMPERATURE ACCELERATES AGGREGATION OF THE LEU-68 -] GLN MUTANT CYSTATIN-C, THE AMYLOID-FORMING PROTEIN IN HEREDITARY CYSTATIN-C AMYLOID ANGIOPATHY [J].
ABRAHAMSON, M ;
GRUBB, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1416-1420
[2]   Analysis of the structural and functional elements of the minimal active fragment of islet amyloid polypeptide (IAPP) - An experimental support for the key role of the phenylalanine residue in amyloid formation [J].
Azriel, R ;
Gazit, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) :34156-34161
[3]   Amyloid fibril formation by Aβ16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR [J].
Balbach, JJ ;
Ishii, Y ;
Antzutkin, ON ;
Leapman, RD ;
Rizzo, NW ;
Dyda, F ;
Reed, J ;
Tycko, R .
BIOCHEMISTRY, 2000, 39 (45) :13748-13759
[4]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[5]   Differential expression of α-synuclein isoforms in dementia with Lewy bodies [J].
Beyer, K ;
Lao, JI ;
Carrato, C ;
Mate, JL ;
López, D ;
Ferrer, I ;
Ariza, A .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2004, 30 (06) :601-607
[6]   Elucidation of primary structure elements controlling early amyloid β-protein oligomerization [J].
Bitan, G ;
Vollers, SS ;
Teplow, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :34882-34889
[7]   Amyloid β-protein oligomerization -: Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins [J].
Bitan, G ;
Lomakin, A ;
Teplow, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :35176-35184
[8]   Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis [J].
Booth, DR ;
Sunde, M ;
Bellotti, V ;
Robinson, CV ;
Hutchinson, WL ;
Fraser, PE ;
Hawkins, PN ;
Dobson, CM ;
Radford, SE ;
Blake, CCF ;
Pepys, MB .
NATURE, 1997, 385 (6619) :787-793
[9]   Nature disfavors sequences of alternating polar and non-polar amino acids: Implications for amyloidogenesis [J].
Broome, BM ;
Hecht, MH .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 296 (04) :961-968
[10]   Rationalization of the effects of mutations on peptide and protein aggregation rates [J].
Chiti, F ;
Stefani, M ;
Taddei, N ;
Ramponi, G ;
Dobson, CM .
NATURE, 2003, 424 (6950) :805-808